Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1586/14737140.2015.1092385
Reference52 articles.
1. Long-term trends in cancer mortality in the United States, 1930-1998
2. Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions
3. Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?
4. Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
5. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations;Nature Communications;2022-11-14
2. Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer;Journal of Pharmacy Practice;2019-06-05
3. Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program;Oncology and Therapy;2018-05-25
4. Zytostatika-assoziierte Toxizitäten in der geriatrischen Onkologie;Geriatrische Onkologie;2018
5. Recent advances in targeted advanced lung cancer therapy in the elderly;Expert Review of Anticancer Therapy;2017-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3